Advanced Search

    Technical Analysis for VRNA - Verona Pharma plc

    Grade Last Price % Change Price Change
    B 22.00 3.82% 0.81
    VRNA closed up 3.82 percent on Monday, February 6, 2023, on 38 percent of normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical VRNA trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 3.82%
    Spinning Top Other 3.82%
    Lower Bollinger Band Walk Weakness 3.82%
    Lower Bollinger Band Touch Weakness 3.82%
    Oversold Stochastic Weakness 3.82%
    New Downtrend Bearish 7.32%
    Multiple of Ten Bullish Other 7.32%
    Below Lower BB Weakness 7.32%
    Lower Bollinger Band Touch Weakness 7.32%
    Oversold Stochastic Weakness 7.32%
    Older End-of-Day Signals for VRNA ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    10 DMA Resistance about 2 hours ago
    Rose Above 10 DMA about 4 hours ago
    Up 3% about 4 hours ago
    Rose Above Previous Day's High about 6 hours ago
    Up 2% about 6 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators Basic chart:

    Profile

    Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company’s lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Enzymes Respiratory Therapy Asthma Respiratory Diseases Pulmonary Disease Chronic Obstructive Pulmonary Disease Cystic Fibrosis Pulmonology Treatment Of Chronic Obstructive Pulmonary Disease Lactams Phosphodiesterase Bronchodilator

    Is VRNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Feb 1 Verona: Second Successful Phase 3 Moves The Needle Forward
    Jan 17 Verona Pharma PLC American Depositary Share (VRNA) Dips More Than Broader Markets: What You Should Know
    Jan 13 Verona Pharma: Breathing Deeply Could Bring Great Benefits
    Jan 10 Verona Pharma PLC American Depositary Share (VRNA) Stock Sinks As Market Gains: What You Should Know
    Jan 3 The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences
    Jan 2 Why These 7 Healthcare Stocks Could Soar in 2023
    Dec 30 American Equity and Avis Budget Stock See Action From Activist Investors
    Dec 30 Hot Stocks: TIGR, FUTU drop on regulatory pressure in China; SJR rises; VRNA sets new high
    Dec 30 4 Drug Stocks That More Than Doubled This Year
    Dec 29 12 Best Performing NASDAQ Stocks in 2022
    See more VRNA news...

    Indicators

    Indicator Value
    52 Week High 26.44
    52 Week Low 3.4078
    Average Volume 1,154,439
    200-Day Moving Average 10.70
    50-Day Moving Average 19.38
    20-Day Moving Average 22.66
    10-Day Moving Average 21.95
    Average True Range 1.53
    RSI 52.38
    ADX 23.35
    +DI 20.90
    -DI 16.55
    Chandelier Exit (Long, 3 ATRs) 21.74
    Chandelier Exit (Short, 3 ATRs) 24.26
    Upper Bollinger Bands 24.72
    Lower Bollinger Band 20.60
    Percent B (%b) 0.34
    BandWidth 18.16
    MACD Line 0.26
    MACD Signal Line 0.75
    MACD Histogram -0.4848
    Fundamentals Value
    Market Cap 1.14 Billion
    Num Shares 51.8 Million
    EPS -2.34
    Price-to-Earnings (P/E) Ratio -9.42
    Price-to-Sales 0.00
    Price-to-Book 1.95
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 24.18
    Resistance 3 (R3) 24.01 23.12 23.81
    Resistance 2 (R2) 23.12 22.57 23.20 23.69
    Resistance 1 (R1) 22.56 22.22 22.84 22.73 23.57
    Pivot Point 21.67 21.67 21.81 21.75 21.67
    Support 1 (S1) 21.11 21.12 21.39 21.28 20.43
    Support 2 (S2) 20.22 20.77 20.30 20.31
    Support 3 (S3) 19.66 20.22 20.19
    Support 4 (S4) 19.83